Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 797-800

  Zhang, Guo An ^a   Hou, Sen ^a,b   Han, Sha ^a   Zhou, Jian ^a   Wang, Xu ^a   Cui, Wen ^a  

^a JINING MEDICAL UNIVERSITY   (China)

^b Biological medicine research institute   (China)

Author keywords

Clinicopathological features; Leptin; Leptin receptors; Papillary thyroid cancer

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADULT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

EID: 84872716182     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1125     Document Type: Article

References (32)

1. Simard EP, Ward EM, Siegel R and Jemal A: Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin: Jan 4, 2012 (Epub ahead of print).
2. Chen AY, Jemal A and Ward EM: Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807, 2009.
3. Olaleye O, Ekrikpo U, Moorthy R, et al: Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol 268: 899-906, 2011.
4. Capezzone M, Morabito E, Bellitti P, Giannasio P, De Sanctis D and Bruno R: Increasing incidence of thyroid cancer in Basilicata: an Italian study. J Endocrinol Invest 30: 507-512, 2007.
5. Smailyte G, Miseikyte-Kaubriene E and Kurtinaitis J: Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer 6: 284, 2006.
6. Liu S, Semenciw R, Ugnat AM and Mao Y: Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 85: 1335-1339, 2001.
7. Xiang J, Wu Y, Li DS, et al: New clinical features of thyroid cancer in eastern China. J Visc Surg 147: e53-e56, 2010.
8. Finucane MM, Stevens GA, Cowan MJ, et al: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377: 557-567, 2011.
9. Wang Y, Mi J, Shan XY, Wang QJ and Ge KY: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31: 177-188, 2007.
10. Chen CM: Overview of obesity in Mainland China. Obes Rev 9 (Suppl 1): 14-21, 2008.
11. Khandekar MJ, Cohen P and Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11: 886-895, 2011.
12. Renehan AG, Tyson M, Egger M, Heller RF and Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578, 2008.
13. Roberts DL, Dive C and Renehan AG: Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61: 301-316, 2010.
14. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.
15. Sweeney G: Leptin signalling. Cell Signal 14: 655-663, 2002.
16. Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol 207: 12-22, 2006.
17. Riolfi M, Ferla R, Del Valle L, et al: Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol 20: 481-489, 2010.
18. Ishikawa M, Kitayama J and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325-4331, 2004.
19. Hoon Kim J, Lee SY, Myung SC, Kim YS, Kim TH and Kim MK: Clinical significance of the leptin and leptin receptor expressions in prostate tissues. Asian J Androl 10: 923-928, 2008.
20. Uddin S, Bu R, Ahmed M, et al: Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer 8: 74, 2009.
21. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E and Sulkowski S: Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 60: 902-906, 2007.
22. Liu H, Wan D, Pan Z, et al: Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochem Biophys 60: 241-244, 2011.
23. Uddin S, Bavi P, Siraj AK, et al: Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer 17: 191-202, 2010.
24. Cheng SP, Chi CW, Tzen CY, et al: Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery 147: 847-853, 2010.
25. Koda M, Sulkowska M, Wincewicz A, et al: Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann NY Acad Sci 1095: 90-98, 2007.
26. Koda M, Sulkowska M, Kanczuga-Koda L, et al: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann Oncol 18 (Suppl 6): vi116-119, 2007.
27. Koda M, Kanczuga-Koda L, Sulkowska M, Surmacz E and Sulkowski S: Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy. BMC Cancer 10: 320, 2010.
28. Garofalo C, Koda M, Cascio S, et al: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 12: 1447-1453, 2006.
29. Chen C, Chang YC, Liu CL, Chang KJ and Guo IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat 98: 121-132, 2006.
30. Cheng SP, Liu CL, Hsu YC, Chang YC, Huang SY and Lee JJ: Regulation of leptin receptor expression in human papillary thyroid cancer cells. Biomed Pharmacother 66: 469-473, 2012.
31. Cheng SP, Yin PH, Chang YC, Lee CH, Huang SY and Chi CW: Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncol Rep 23: 1721-1727, 2010.
32. Cheng SP, Yin PH, Hsu YC, et al: Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol Rep 26: 1265-1271, 2011.